Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Ambrx Biopharma Inc ADR (AMAM)

Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,768,200
  • Shares Outstanding, K 63,150
  • Annual Sales, $ 7,400 K
  • Annual Income, $ -78,000 K
  • 60-Month Beta -1.92
  • Price/Sales 1,929.31
  • Price/Cash Flow N/A
  • Price/Book 6.18
Trade AMAM with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.58
  • Most Recent Earnings $-0.05 on 08/09/23
  • Next Earnings Date 04/04/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.41
  • Number of Estimates 2
  • High Estimate -0.36
  • Low Estimate -0.45
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
27.51 +1.78%
on 02/20/24
28.03 -0.11%
on 02/26/24
+0.22 (+0.79%)
since 02/06/24
3-Month
11.74 +138.50%
on 12/12/23
28.15 -0.53%
on 01/10/24
+15.97 (+132.75%)
since 12/06/23
52-Week
6.55 +327.48%
on 10/23/23
28.15 -0.53%
on 01/10/24
+15.46 (+123.29%)
since 03/06/23

Most Recent Stories

More News
Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson

These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns?

KVUE : 21.99 (-0.77%)
AMAM : 28.00 (+0.07%)
UNH : 583.56 (-1.29%)
JNJ : 159.53 (-0.47%)
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

ONCY : 1.4000 (+27.27%)
ONC.TO : 1.91 (+28.19%)
AMGN : 317.45 (-0.69%)
AMAM : 28.00 (+0.07%)
ELEV : 0.5424 (+0.74%)
NKTX : 3.84 (-2.04%)
Johnson & Johnson: Biotech a shot in the arm for future growth?

Johnson & Johnson is actively shifting its strategy towards biotechnology and antibody-drug conjugates, balancing current revenue protection with future growth.

JNJ : 159.53 (-0.47%)
AMAM : 28.00 (+0.07%)
Markets Today: Stocks Edge Higher on Hopes Israeli-Hamas Conflict Can Be Contained

Morning Markets December E-Mini S&P 500 futures (ESZ2 3) are up +0.38%, and the Dec Nasdaq 100 E-Mini futures (NQZ2 3) are up +0.22%. Stock index futures this morning are moderately higher as the markets...

ESZ24 : 5,745.25 (+0.01%)
NQZ24 : 19,994.75 (+0.01%)
LULU : 272.48 (+0.78%)
HUBB : 438.43 (+2.03%)
VFS : 3.74 (-1.84%)
ALSN : 99.37 (+0.32%)
DXCM : 68.62 (+0.75%)
CL : 98.57 (-0.47%)
CART : 41.95 (+3.81%)
AMAM : 28.00 (+0.07%)
AAPL : 221.69 (-2.25%)
PFE : 29.20 (+2.17%)
Why Shares of Ambrx Biopharma Soared This Week

A big buy by an asset manager spurred interest in the biotech stock.

AMAM : 28.00 (+0.07%)
Why Shares of Ambrx Biopharma Jumped This Week

The company reported data on its clinical programs at two conferences this week.

RY : 121.76 (-0.54%)
RY.TO : 165.90 (-0.18%)
AMAM : 28.00 (+0.07%)
Ambrx Raises $78 Million and Completes its ATM Program

Ambrx Biopharma Inc., or Ambrx (NYSE: AMAM), today announced that it has completed net sales of approximately $78 million of American Depositary Shares (“ADSs”) pursuant to the Company’s at-the-market...

AMAM : 28.00 (+0.07%)
Why Shares of Ambrx Biopharma Fell Tuesday

After getting a bump on Monday for its switch to the Nasdaq Stock Market, there was a bit of a correction.

AMAM : 28.00 (+0.07%)
Potential Earnings Have Rated Ambrx Biopharma a Moderate Buy

Ambrx Pharmaceuticals, Inc. could see positive earnings next year. And while share value could go down, analysts thin rate AMAM a Moderate Buy

AMAM : 28.00 (+0.07%)
MOLN : 4.76 (-5.18%)
Ambrx to Commence Trading on Nasdaq

Ambrx Biopharma Inc. (NYSE: AMAM ) (“Ambrx” or “the Company”) today announced that it will voluntarily transfer its stock exchange listing to the Nasdaq Stock Market from the New York Stock Exchange,...

AMAM : 28.00 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 28.03
2nd Resistance Point 28.01
1st Resistance Point 28.01
Last Price 28.00
1st Support Level 27.99
2nd Support Level 27.97
3rd Support Level 27.97

See More

52-Week High 28.15
Last Price 28.00
Fibonacci 61.8% 19.90
Fibonacci 50% 17.35
Fibonacci 38.2% 14.80
52-Week Low 6.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar